Extract notice to the Minister
Nucala (MPOC)
Common name / Subject : mépolizumab
Name of the manufacturer : GSK
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : 100 mg/ml (1 ml)
Name of the manufacturer : GSK
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : 100 mg/ml (1 ml)
Indication : Maladie pulmonaire obstructive chronique (MPOC)
INESSS' Recommendation
Refus d’inscription – Ensemble des aspects
Minister's decisions
À venir
Evaluation published on July 28, 2026
INESSSid: 27215
Recevable on July 28, 2025